![](/img/cover-not-exists.png)
The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis
Nicolini, F. E., Ibrahim, A. R., Soverini, S., Martinelli, G., Muller, M. C., Hochhaus, A., Dufva, I. H., Kim, D.-W., Cortes, J., Mauro, M. J., Chuah, C., Labussiere, H., Morisset, S., Roche-LestienneVolume:
98
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2012.080234
Date:
October, 2013
File:
PDF, 650 KB
english, 2013